NAMSA expands medical device testing services

Share

NAMSA (Toledo, Ohio) recently announced that it has launched its Analytical Services Laboratory in Obernburg, Germany to further expand access to accelerated product development and testing services.

The company’s new facility offers European device manufacturers a facility that meets ISO 10993-18 testing requirements. It will also offer exhaustive extraction, FTIR, GC-MS, LC-MS and ICP-MS services in that region.

“NAMSA is excited to add to its global portfolio of services with the introduction of its new Obernberg laboratory,” Ulrich Gohlke, director of German lab operations, said in a press release. “NAMSA is proud of its strong working relationships with EU regulatory entities, including the European Commission, and demonstrated track record of delivering significant time and cost savings throughout the medical device development continuum. With the introduction of NAMSA’s new Analytical Services Laboratory, we look forward to providing European device makers significant development efficiencies, including closer collaboration through an ideally-located testing partner.”

NAMSA’s Analytical Services Laboratory will have its grand opening on March 6. The company will offer laboratory tours, complimentary consultations, scientific sessions, keynote addresses and a networking reception at the lab’s launch.

Join the Best Minds in MedTech at DeviceTalks Minnesota!

textadimage This year’s DeviceTalks Minnesota features four tracks packed with expertly curated content created by the industry for the industry.

ECO-SYSTEM TRACK: focuses on issues impacting medtech companies across Minnesota and beyond. TECHNOLOGY TRACK: drills down on the hottest new tech that is changing medtech. REGULATORY 201 and CLINCAL 201 TRACKS: Hosted by Medical Alley and focuses on the most important trends in regulatory and clinical development.

Take a look at our full agenda.

Use the code "TRACKS" to save 15% on the cost of registration. 

REGISTER TODAY

Speak Your Mind

*